Giloralimab (ABBV-927) is a CD40-targeting agonist monoclonal antibody with potential anticancer activity, intended for use in the study of triple-negative breast cancer and non-small cell lung cancer.
Purity:
95.10%
CAS Number:
[2226292-20-0]
Target:
TNF
T82320
* VAT and and shipping costs not included. Errors and price changes excepted